Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Entourage Health Corp. (ETRGF)

Compare
0.0030
0.0000
(0.00%)
At close: 3:03:18 PM EDT
Loading Chart for ETRGF
  • Previous Close 0.0030
  • Open 0.0030
  • Bid 0.0030 x --
  • Ask 0.0035 x --
  • Day's Range 0.0030 - 0.0030
  • 52 Week Range 0.0029 - 0.0148
  • Volume 1,100
  • Avg. Volume 52,571
  • Market Cap (intraday) 1.079M
  • Beta (5Y Monthly) 1.81
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1000
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary's Medicinals, and Royal City Cannabis brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Aylmer, Canada.

entouragehealthcorp.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ETRGF

View More

Performance Overview: ETRGF

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

ETRGF
52.76%
S&P/TSX Composite index (^GSPTSE)
1.16%

1-Year Return

ETRGF
62.12%
S&P/TSX Composite index (^GSPTSE)
10.05%

3-Year Return

ETRGF
96.08%
S&P/TSX Composite index (^GSPTSE)
10.85%

5-Year Return

ETRGF
98.95%
S&P/TSX Composite index (^GSPTSE)
88.09%

Compare To: ETRGF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ETRGF

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    1.08M

  • Enterprise Value

    125.81M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.03

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    4.34

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -101.69%

  • Return on Assets (ttm)

    -30.93%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    41.46M

  • Net Income Avi to Common (ttm)

    -42.16M

  • Diluted EPS (ttm)

    -0.1000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.52M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -17.78M

Research Analysis: ETRGF

View More

Company Insights: ETRGF

Research Reports: ETRGF

View More

People Also Watch